Calcium dobesilate

CAS No. 20123-80-2

Calcium dobesilate( —— )

Catalog No. M20557 CAS No. 20123-80-2

Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 37 In Stock
1G 52 In Stock

Biological Information

  • Product Name
    Calcium dobesilate
  • Note
    Research use only, not for human use.
  • Brief Description
    Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.
  • Description
    Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cardiovascular Disease
  • Indication
    Diabetic microvascular disease varicose veins syndrome

Chemical Information

  • CAS Number
    20123-80-2
  • Formula Weight
    418.41
  • Molecular Formula
    C12H10CaO10S2?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (358.50 mM)
  • SMILES
    [Ca++].Oc1ccc(O)c(c1)S([O-])(=O)=O.Oc1ccc(O)c(c1)S([O-])(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhou Y Yuan J Qi C et al.Calcium dobesilate may alleviate diabetes?induced endothelial dysfunction and inflammation.Mol Med Rep[J]. 2017 Dec;16(6):8635-8642.
molnova catalog
related products
  • Bupleuroside XIII

    Bupleuroside XIII is a natural hepatoprotective saponin.

  • GSK-3 inhibitor 3

    GSK-3 inhibitor 3 is a selective, orally active, brain-permeable GSK-3 inhibitor that inhibits GSK-3α and GSK-3β with IC50s of 0.35 nM and 0.25 nM, respectively.

  • 3,5-Di-O-caffeoylqui...

    3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.